Topics

eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test

10:24 EST 7 Nov 2019 | Xconomy

Biotech startup eGenesis, which is applying gene editing to animal organs in order to make them suitable for human transplant, has raised $100 million to ramp work on its kidney program and bring it into human testing. The Series B round of funding was led by the investment arm of Fresenius Medical Care Ventures, a […]

Original Article: eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test

NEXT ARTICLE

More From BioPortfolio on "eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...